Translational Cancer Research

Papers
(The TQCC of Translational Cancer Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma70
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study64
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report42
Molecular basis of heterogeneity in small cell lung cancer35
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn26
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study25
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial24
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer22
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study20
Construction of molecular subtypes and prognostic model for breast cancer based on sulfur metabolism-related genes20
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors20
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?19
Identification of neuronal synapse-related signatures and potential therapeutic drugs in colorectal cancer based on machine learning algorithms and molecular docking19
Key considerations for interpreting patient-reported outcomes in deep inferior epigastric artery perforator flap reconstruction with post-mastectomy radiotherapy19
Unveiling prognostic factors and predictive modeling in lung adenocarcinoma with neuroendocrine differentiation18
Clinicopathological characteristics and long-term prognosis of duodenal signet ring cell carcinoma: a SEER-based analysis18
Development and validation of a prognosis model for patients with brain-metastasis non-small cell lung cancer by machine-learning18
Effects of p-cresol, a uremic toxin, on cancer cells18
Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma17
MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis17
Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes17
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma17
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis17
Diagnostic value of double low-dose targeted perfusion CT imaging for the diagnosis of invasive and preinvasive pulmonary ground-glass nodules: systematic review and meta-analysis16
Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study16
Treatment of immune checkpoint inhibitor-related colitis: a narrative review16
Construction of a prognostic model for lung adenocarcinoma based on necroptosis genes and its exploration of the potential for tumor immunotherapy15
Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases14
Development and validation of a clinical diagnostic model for surgical site infection after surgery in patients with gastric cancer14
A prediction model of gastric cancer based on M2-like tumor-associated macrophage infiltration verified by immunohistochemistry14
The association between ephrin receptor-A1 expression and survival in patients with cancer: a meta-analysis14
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma14
Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review14
Targeted next-generation sequencing reveals genomic differences between male and female breast cancer13
A circadian clock gene-related signature for predicting prognosis and its association with sorafenib response in hepatocellular carcinoma13
Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment13
Development and validation of a circulating tumor DNA-based machine learning model for predicting immunotherapy response in non-small cell lung cancer13
Incorporating host genetics and inflammation in myelosuppression risk prediction for triple-negative breast cancer13
An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer13
CLCN3 in mediating the proliferation of human ovarian cancer cells13
miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer13
The prognostic value and mechanisms of centromere protein M in patients with lung adenocarcinoma13
Expression analyses of fatty acid binding proteins (FABPs) in breast cancer subtypes: implications for immune modulation and clinical outcomes12
Research progress in predicting visceral pleural invasion of lung cancer: a narrative review12
Results of the feasibility study of clinical trials of the new cancer treatment technology Karanahan for patients with advanced breast cancer12
Prognostic significance of lymph node-related indices and a novel nomogram for rectal cancer patients with synchronous liver metastases after the preoperative chemoradiotherapy: a population-based stu12
Clinical pathological characteristics correlation of H3F3A gene mutation in giant cell tumor of bone: a study of 96 cases12
Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients12
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer12
Utilization of intraoperative indocyanine green fluorescence imaging to identify vascular anatomy in severe pleural adhesions in uniportal video-assisted thoracoscopic surgery: a case report12
Comprehensive analysis and validation of the prognostic value of glycosylation- and mitophagy-related genes for head and neck squamous cell carcinoma12
Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy12
Metformin suppressed epithelial-mesenchymal transition, cisplatin resistance and metastatic potential of ovarian cancer via inhibiting TGF-β1/Smads12
Diagnostic performances of skin cancers using intensity- and gradient-based features with optical coherence tomography: a pilot study12
Identification of prognostic immune-related genes and evaluation of chemotherapy and immunotherapy responses in pancreatic cancer11
TOP2A promotes non-small cell lung cancer progression via LDHA-mediated glycolysis and histone lactylation11
Association of branched-chain amino acids and risk of three urologic cancers: a Mendelian randomization study11
A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance11
Combining Bulk RNA-seq and scRNA-seq data to identify RNA m5C methyltransferases NSUN1: a rising star as a biomarker for cancer diagnosis, prognosis and therapy11
Gastric cancer prognosis: unveiling autophagy-related signatures and immune infiltrates11
Immunotherapy for combined pulmonary fibrosis and emphysema with advanced lung cancer: two case reports and a concise review11
Knockdown of TRIM35 suppresses cell proliferation and metastasis by modulating the PPAR signalling pathway in papillary thyroid cancer cells11
Identification and validation of tumor microenvironment remodeling markers associated with prognosis in differentiated thyroid cancer11
PTPMT1 inhibition induces apoptosis and growth arrest of human SCLC cells by disrupting mitochondrial metabolism11
Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteria10
Oncologic and obstetric outcomes of a novel nerve-sparing radical trachelectomy while preserving the uterine branches of the pelvic nerves10
The value of an integrated multi-omics model in the diagnosis of benign and malignant pulmonary nodules10
ATP5A1 as a potential prognostic biomarker in clear-cell renal cell carcinoma10
DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway10
Three-dimensional model to simulate esophagectomy in patients with a mediastinal vascular anomaly: to see is to believe10
The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial10
Analysis and assessment of ferroptosis-related gene signatures and prognostic risk models in skin cutaneous melanoma10
Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations10
Efficacy, cardiotoxicity and factors affecting pathologic complete response of neoadjuvant chemotherapy with anthracycline-containing verses anthracycline-free regimens plus dual HER2 blockade for HER10
Allogeneic CAR-T bridging to allo-HSCT as a treatment strategy for refractory adult Burkitt’s lymphoma: a case report10
Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study10
A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer10
Problems and countermeasures for surgical resection of primary pulmonary artery intimal sarcoma10
The mechanism and research progress of PD-1/PD-L1 on immune escape of lung cancer10
Bridging histopathology, inferred transcriptomics, and immunotherapy response prediction in head and neck cancer10
Value of ZSCAN9 in the treatment and survival prediction of hepatocellular carcinoma: a bioinformatics study9
Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer9
Construction of a prognostic signature for breast cancer based on genes involved in unsaturated fatty acid biosynthesis9
Development and internal validation of a multivariable prognostic prediction model in advanced breast cancer patients based on the SEER database9
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification9
Explainable machine-learning prediction of overall and cancer-specific survival in adult triple-negative breast cancer using SEER: a comparative study of nomograms and random survival forests9
Artificial intelligence applications in adaptive radiotherapy—a narrative review9
Prognostic implications of a programmed cell death-related long non-coding RNA signature and its relevance to immune features in esophageal carcinoma9
Experience with flap repair after vulvar carcinoma resection: a retrospective observational study of 26 cases9
Development and validation of nomogram-based models for personalized survival assessment in pediatric hepatoblastoma patients9
Undifferentiated embryonic sarcoma of the adult liver with paraneoplastic syndrome: a case report9
Study on the prevalence and subtypes of human papillomavirus infection among women in the Xuhui District, Shanghai City, China9
Magnetic resonance imaging-based radiomics analysis: predicting vascular invasion in breast invasive ductal carcinoma using different machine learning models9
The association of tumor diameter with lymph node metastasis and recurrence in patients with endometrial cancer: a systematic review and meta-analysis9
Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1–2M1 renal cell carcinoma9
Intratumoral disulfidptosis heterogeneity in triple-negative breast cancer, a multiomics integration analysis9
Prognostic development and validation of a prediction model based on major histocompatibility complex-related differentially expressed genes in stomach adenocarcinoma9
A narrative review of papillary thyroid carcinoma-related long non-coding RNAs and their relevance to malignant tumors9
Stemness-hypoxia genes PPARGC1A, PFKFB3, and SLC2A5 are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma9
EPB41L4A-AS1 regulates cervical cancer by proliferative cells: mendelian randomization and single-cell transcriptomics analyses9
Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma9
Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma9
OSBPL3 promotes colorectal cancer progression through modulation of TGF-β signaling and immune cell infiltration9
Targeting the gut microbiota-metabolite-immune axis in cancer immunotherapy: mechanistic interplay, therapeutic strategies, and translational applications-a narrative review9
MicroRNA-663a upregulation upon ARID1A depletion promotes the growth and migration of esophageal cancer cells by targeting FKBP89
Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?9
Association between human epidermal growth factor receptor 2 status, namely low and zero expression, and prognosis in hormone receptor-positive breast cancer: a single-center retrospective study8
Glutamine metabolism drives tumor aggressiveness but not chemoresistance in ovarian carcinoma cell lines8
KIF18A and CDK1 as combined therapeutic targets in cervical and endometrial carcinomas: based on bioinformatics analysis and in vitro experiments8
A nomogram for predicting overall survival in advanced hepatocellular carcinoma patients receiving radiotherapy combined with targeted therapy: a multicenter retrospective study8
MicroRNA-125b inhibits apoptosis and increases gemcitabine resistance by downregulating the expression of BAK1 in pancreatic ductal adenocarcinoma8
Harnessing natural killer cell-related genes for prognostic and therapeutic advances in lung adenocarcinoma: a predictive model for survival and immunotherapy outcomes8
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review8
ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cel8
Prognostic significance of chemotherapy response score in predicting outcomes for high-grade serous ovarian carcinoma patients undergoing neoadjuvant chemotherapy8
Comprehensive analysis of gene signature linking hypoxia and lactylation for predicting prognosis and immunotherapy response in patients with gastric cancer8
Comparison of the short-term outcomes of open and laparoscopic hepatectomy in the treatment of recurrent hepatocellular carcinoma: a single-center retrospective study8
Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database8
Role of PDGFA expression in the prognosis of head and neck squamous cell carcinoma: construction of prognostic nomogram and functional mechanism exploration8
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis8
Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling8
Clinical efficacy and safety of pyrotinib as the first-line treatment of HER2-positive advanced breast cancer in Xinjiang Uygur Autonomous Region of China8
Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges8
An immune-related miRNA signature predicts the prognosis in nasopharyngeal carcinoma8
Women’s hormonal health research and care: the times, they are a-changin’8
Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR8
High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer8
Risk factors, prognostic factors and nomograms for distant metastasis in colorectal neuroendocrine neoplasms: a SEER-based study8
Inhibitory effects of LOXL2 knockdown on cellular functions of liver cancer stem cells8
Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma8
FXR activation suppresses NF-κB signaling, proliferation and migration in cervical cancer cells8
A newly identified pyroptosis-related gene signature for predicting prognosis of patients with hepatocellular cancer8
Telomere-related gene risk model for prognosis prediction in colorectal cancer8
Advances in genomic biomarkers for lethal metastatic castration-resistant prostate cancer8
Integrative analysis of CRISPR screening and gene expression data identifies a three-gene prognostic model associated with immune microenvironment in neuroblastoma8
Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro8
Exploring potential causal genetic variants and genes for endometrial cancer: Open Targets Genetics, Mendelian randomization, and multi-tissue transcriptome-wide association analysis8
A novel mesenchymal epithelial transition (MET) inhibitor, CB538, relieves acquired resistance in EGFR-mutated MET-amplified non-small cell lung cancer8
Identification of basement membrane-based prognostic signature and potential therapeutic drugs in hepatocellular carcinoma8
Uterine intravascular leiomyomatosis involves the heart: a case report and literature review8
Identification of Fanconi anemia pathway genes as novel prognostic biomarkers and therapeutic targets for breast cancer8
Nomogram for predicting cancer-specific mortality risk in endometrial cancer after postoperative radiotherapy8
Prediction of mortality in patients with retinoblastoma based on random survival forest: a retrospective cohort analysis using SEER database8
Catheter-directed thrombectomy combined with angioplasty and stent implantation for superior vena cava syndrome: a case report8
Increased expression of HBXIP (LAMTOR5) predicts poor prognosis and is correlated with immune-cell infiltration in glioma8
Comparison of 5-year survival rates and prognostic factors between adenoid cystic carcinoma and squamous cell carcinoma of the maxillary sinus: a SEER database analysis8
Development of a prognostic nomogram for colorectal cancer with peritoneal metastasis: a SEER database analysis8
IL-6 promotes metastasis and EMT of non-small cell lung cancer cells by up-regulating FGL1 via STAT3 pathway8
Study on the value of multi-dimensional conformal radiotherapy and functional imaging in tumor bioimaging7
Prognostic value of preoperative combined with postoperative systemic immune-inflammation index for disease-free survival after radical rectal cancer surgery: a retrospective cohort study7
Predictive model of gene expression regulating invasion and migration of M2 macrophages in breast cancer: clinical prognosis and therapeutic implications7
Erratum to lncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p7
LINC02081 as an oncogene promotes cell proliferation and G2/M cycle through p53 signaling pathway in lung adenocarcinoma7
The pan-cancer landscape of crosstalk between leukocyte transendothelial migration-related genes and tumor microenvironment relevant to prognosis and immunotherapy response7
Development and validation of a prognostic predictive model of pulmonary spindle cell carcinoma from the surveillance, epidemiology and end results database7
GNAL-driven calcium signaling reshapes the spatiotemporal immune landscape in ER+ breast cancer: causal insights and prognostic implications7
The flavonoid astragalin induces apoptosis in lung adenocarcinoma and correlates with a prognostic cell cycle gene signature associated with PANoptosis7
Slamming hepatocellular carcinoma: targeting immunosuppressive macrophages via SLAMF7 reprograms the tumor microenvironment7
Construction of a prognosis model of head and neck squamous cell carcinoma pyroptosis and an analysis of immuno-phenotyping based on bioinformatics7
Expression of copper metabolism-related genes is associated with the tumor immune microenvironment and predicts the prognosis of hepatocellular carcinoma7
Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis7
Comparable prognosis of early gastric cancer between intestinal type and diffuse type in patients of age 75 and older: a SEER-based cohort study7
LAPTM5-dependent lipophagy enhances ferroptosis sensitivity in glioma cells7
The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta7
Exosomal microRNAs in lung cancer: a narrative review7
Identification and validation of hypoxia-associated genes positively correlated with HIF1A in pulmonary adenocarcinoma7
Efficacy of transarterial chemoembolization combined with PD-1 versus PD-L1 inhibitors in mass-forming intrahepatic cholangiocarcinoma: a multicenter retrospective study7
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre7
New model for remote symptom management and self-care of cancer patients based on digital health platforms: a narrative review7
Single-cell analysis revealed a diagnostic model of hepatocellular carcinoma based on cancer stem cell-related gene7
CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy7
Comprehensive analysis of tumor immune-related gene signature for predicting prognosis, immunotherapy, and drug sensitivity in bladder urothelial carcinoma7
Key genes and pathway differences between serrated polyps and conventional adenomas: insights from multi-omics7
Survival analysis of gastric malignancy patients: identifying key prognostic factors7
Identification of hub genes and key modules in laryngeal squamous cell carcinoma7
B7-H3 promotes proliferation and migration of lung cancer cells by modulating PI3K/AKT pathway via ENO1 activity7
Preliminary exploration of the potential biological functions and prognosis values of RAB4B in pan-cancer combing with experimental validation in BLCA7
Winning hearts & minds: prostate cancer outreach and clinical trial enrollment in minority men7
Effect and mechanism of auranofin on extrusion and migration of breast cancer cells7
Durable clinical response to ALK tyrosine kinase inhibitors in ALK-rearranged non-small cell lung cancer: a case report7
Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database7
Uridine-cytidine kinase 2 as a novel potential prognostic and therapeutic biomarker in gastric cancer7
KCNK9 could be a prognostic biomarker in uterine corpus endometrial carcinoma7
Molecular mechanism of miR-27a-3p targeting FBXW7 regulating the malignant behavior of osteosarcoma cells7
Effect of periplocin on malignant behavior of oral squamous cell carcinoma cells7
Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer7
Secretogranin II serves as a potential prognostic biomarker and correlates with the immune microenvironment in pancreatic neuroendocrine tumors7
Oncologic outcome of breast reconstruction after mastectomy in breast cancer: a systematic review and meta-analysis7
A prognostic model for laryngeal squamous cell carcinoma based on the mitochondrial metabolism-related genes7
Prognostic significance of alterations in peripheral cellular and humoral immune biomarkers during radiochemotherapy in head and neck cancer patients7
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells7
The expression of programmed cell death ligand 1 (PD-L1) involves in the clinicopathologic characteristics and prognostic implications of testicular germ cell tumor (TGCT): a systematic review and met7
Role of 18F-FDG PET/CT in the diagnosis and treatment response assessment of primary pulmonary lymphoma7
Optimizing immunotherapy for lung cancer: integrating genetic alterations and the tumor mutational burden to refine patient selection7
Herpes simplex virus-thymidine kinase/ganciclovir suppressed the growth of lung adenocarcinoma cells accompanied by premature senescence7
Proteome-wide identification and functional analysis of ubiquitinated proteins in Hepa1-6 cells by knockdown of E3 ubiquitin ligase SIAH17
Efficacy of relative dose intensity of nab-paclitaxel for the short-term outcomes, survival, and quality of life in patients with advanced pancreatic cancer: a retrospective study7
Real-time prognosis prediction with conditional survival analysis for skull base chordoma based on SEER6
Genomic analysis of the endosomal sorting required for transport complex III pathway genes as therapeutic and prognostic biomarkers for endometrial carcinoma6
Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up?6
Exploring the lactate-metabolism related characteristics during the development of medulloblastoma through single-cell and bulk RNA-seq6
CCND2 is a prognostic biomarker and correlates with immune infiltration in lung adenocarcinoma6
Identification of the key gene for hepatocellular carcinoma based on bioinformatics and machine learning and experimental verification6
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non-small cell lung cancer6
Integrating WGCNA and machine learning algorithm to identify ACSM5 as a prognostic biomarker and therapeutic target for predicting immunotherapy efficacy in non-small cell lung cancer6
Targeting the MICA/B-NKG2D axis in cancer: from molecular structure to immunotherapeutic strategies—a narrative review6
Retraction: H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition6
A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes6
Prognostic and immunological significance of peroxisome proliferator-activated receptor gamma in hepatocellular carcinoma based on multiple databases6
Development and feasibility assessment of an automated, synthetic CT-guided plan selection system for bladder cancer adaptive radiotherapy: a retrospective pilot study6
FLAURA2: evidence for escalated first-line therapy in EGFR-mutated non-small cell lung cancer with central nervous system metastases6
Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?6
Single-cell and bulk transcriptomic analyses identify B-cell senescence-associated biomarkers in papillary thyroid carcinoma6
Radiation induced lung injury (RILI) after postoperative intensity modulated proton therapy (IMPT) in a patient with stage III locally advanced lung adenocarcinoma: a case report6
Beyond survival: the role of quality of life in modern urothelial cancer therapy6
The claudin-18.2-CD3 bispecific antibody IBI389 exerts an antitumor effect on malignant tumors with positive claudin-18.2 expression by promoting T-cell infiltration and remodeling the tumor immune mi6
Investigating the material basis and molecular mechanisms of Oldenlandia diffusa in the treatment of papillary thyroid carcinoma: a network pharmacology and experimental study6
Establishment of a prognostic model and immune profiling based on phagocytic regulatory genes in hepatocellular carcinoma6
PM2.5 promotes non-small cell lung cancer tumorigenesis by miR-21-5p targeting PDE4DIP accumulated6
Liquid-liquid phase separation-related gene signature characterizes prognostic subtypes and therapeutic sensitivities in gastric cancer6
Liquid biopsy for the detection of non-viral head and neck squamous cell carcinoma6
Comprehensive profiling of cell subsets of gastric cancer and liver metastasis based on single cell RNA-sequencing analysis6
Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review6
Clinical and prognostic implications of KRT19 expression in pancreatic ductal adenocarcinoma6
Fusobacterium nucleatum and IL-32 co-predict nodal metastasis preoperatively in head and neck cancer6
The peripheral CD4+ T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatment6
Feasibility and safety of transarterial chemoembolization in patients with liver cancer via the distal radial approach: a single-center retrospective cohort study6
Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the PRDX4 gene in gastric cancer based on a data mining analysis6
Development and validation of a machine learning-based prognostic model using mitochondrial dysfunction-related genes for colorectal cancer patients6
Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors6
Radiomic signatures of brain metastases on MRI: utility in predicting pathological subtypes of lung cancer6
Pathomics signatures and cuproptosis-related genes signatures for prediction of prognosis in patients with hepatocellular carcinoma6
The prognostic value of immune escape-related genes in lung adenocarcinoma6
The influence of CXCL9 on M2 macrophages in lung cancer development6
Association of CAB39L gene methylation in peripheral blood leukocytes with the risk, chemotherapy efficacy and prognosis of gastric cancer and construction of risk prediction model6
Efficacy and potential mechanism of main active ingredients of Astragalus membranaceus in animals with hepatocellular carcinoma: a systematic review and meta-analysis6
A signature of four ferroptosis-related genes in laryngeal squamous cell carcinoma6
Development and validation of a pathomics model to predict SOX11 expression and prognosis in hepatocellular carcinoma6
Apoptosis signaling and cancer targeted therapy: from bench to bespoke6
A novel prognostic model based on endoplasmic reticulum stress-associated E3 ligases and deubiquitinating enzymes in hepatocellular carcinoma6
A real-world retrospective cohort study: the clinical outcomes and characteristics of platinum-resistant recurrent ovarian cancer6
Erratum: miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer6
UBA6 serves as a prognostic biomarker and promotes tumor progression in pancreatic ductal adenocarcinoma6
Screening of postoperative adjuvant chemotherapy-related serum metabolic markers in breast cancer patients based on 1H NMR metabonomics6
Molecular characterization and prognostic modeling of liquid- liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysis6
Suppression of hepatocellular carcinoma progression by long noncoding RNA apolipoprotein C1 pseudogene via the regulation of the microRNA-106b-PTEN axis6
The effects of the tumor suppressor gene PTEN on the proliferation and apoptosis of breast cancer cells via AKT phosphorylation6
Potential added value of computed tomography radiomics to multimodal prediction models for benign and malignant breast tumors6
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes6
High-sensitivity modified Glasgow prognostic score (HS-mGPS) is a prognostic biomarker for small duct-type intrahepatic cholangiocarcinoma—a retrospective cohort study6
0.28999519348145